GB201521456D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB201521456D0
GB201521456D0 GBGB1521456.2A GB201521456A GB201521456D0 GB 201521456 D0 GB201521456 D0 GB 201521456D0 GB 201521456 A GB201521456 A GB 201521456A GB 201521456 D0 GB201521456 D0 GB 201521456D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1521456.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mexichem Fluor SA de CV
Original Assignee
Mexichem Fluor SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mexichem Fluor SA de CV filed Critical Mexichem Fluor SA de CV
Priority to GBGB1521456.2A priority Critical patent/GB201521456D0/en
Publication of GB201521456D0 publication Critical patent/GB201521456D0/en
Priority to EP19178832.2A priority patent/EP3556347B1/en
Priority to ES16822716T priority patent/ES2796177T3/en
Priority to EP20169450.2A priority patent/EP3701940A1/en
Priority to BR122020022602-1A priority patent/BR122020022602B1/en
Priority to PCT/GB2016/053812 priority patent/WO2017093758A1/en
Priority to ES19178843T priority patent/ES2866175T3/en
Priority to MX2018006800A priority patent/MX2018006800A/en
Priority to US15/781,045 priority patent/US11559505B2/en
Priority to EP16822716.3A priority patent/EP3383366B1/en
Priority to CN202011316904.7A priority patent/CN112472689B/en
Priority to CN201680071126.5A priority patent/CN108289843B/en
Priority to EP19178843.9A priority patent/EP3556348B1/en
Priority to ES19178832T priority patent/ES2869176T3/en
Priority to CA3007050A priority patent/CA3007050C/en
Priority to BR112018011266-6A priority patent/BR112018011266B1/en
Priority to JP2018528946A priority patent/JP6899824B2/en
Priority to AU2016364650A priority patent/AU2016364650B2/en
Priority to AU2019202875A priority patent/AU2019202875B2/en
Priority to AU2019202874A priority patent/AU2019202874C1/en
Priority to US16/575,168 priority patent/US11559507B2/en
Priority to US16/575,069 priority patent/US11559506B2/en
Priority to JP2019232074A priority patent/JP6899889B2/en
Priority to JP2019232073A priority patent/JP6931383B2/en
Ceased legal-status Critical Current

Links

GBGB1521456.2A 2015-12-04 2015-12-04 Pharmaceutical composition Ceased GB201521456D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB1521456.2A GB201521456D0 (en) 2015-12-04 2015-12-04 Pharmaceutical composition
AU2016364650A AU2016364650B2 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
CN202011316904.7A CN112472689B (en) 2015-12-04 2016-12-02 Pharmaceutical composition
EP19178843.9A EP3556348B1 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
EP20169450.2A EP3701940A1 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
BR122020022602-1A BR122020022602B1 (en) 2015-12-04 2016-12-02 PHARMACEUTICAL COMPOSITION
PCT/GB2016/053812 WO2017093758A1 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
ES19178843T ES2866175T3 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
MX2018006800A MX2018006800A (en) 2015-12-04 2016-12-02 Pharmaceutical composition.
US15/781,045 US11559505B2 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
EP16822716.3A EP3383366B1 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
EP19178832.2A EP3556347B1 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
CN201680071126.5A CN108289843B (en) 2015-12-04 2016-12-02 Pharmaceutical composition
ES16822716T ES2796177T3 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
ES19178832T ES2869176T3 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
CA3007050A CA3007050C (en) 2015-12-04 2016-12-02 Pharmaceutical composition comprising a formoterol compound
BR112018011266-6A BR112018011266B1 (en) 2015-12-04 2016-12-02 Pharmaceutical composition, sealed container, and, methods for treating a patient suffering from or prone to suffering from a respiratory disorder and for stabilizing a pharmaceutical composition
JP2018528946A JP6899824B2 (en) 2015-12-04 2016-12-02 Pharmaceutical composition
AU2019202874A AU2019202874C1 (en) 2015-12-04 2019-04-24 Pharmaceutical composition
AU2019202875A AU2019202875B2 (en) 2015-12-04 2019-04-24 Pharmaceutical composition
US16/575,168 US11559507B2 (en) 2015-12-04 2019-09-18 Pharmaceutical composition
US16/575,069 US11559506B2 (en) 2015-12-04 2019-09-18 Pharmaceutical composition
JP2019232074A JP6899889B2 (en) 2015-12-04 2019-12-23 Pharmaceutical composition
JP2019232073A JP6931383B2 (en) 2015-12-04 2019-12-23 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1521456.2A GB201521456D0 (en) 2015-12-04 2015-12-04 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB201521456D0 true GB201521456D0 (en) 2016-01-20

Family

ID=55234444

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1521456.2A Ceased GB201521456D0 (en) 2015-12-04 2015-12-04 Pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB201521456D0 (en)

Similar Documents

Publication Publication Date Title
IL265360B (en) Pharmaceutical composition
IL265260B (en) Pharmaceutical composition
GB201409471D0 (en) Pharmaceutical composition
IL262654A (en) Pharmaceutical composition
IL265349A (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
LT3278801T (en) Pharmaceutical composition containing mirabegron
GB201506526D0 (en) Medicinal composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201521462D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (en) Pharmaceutical compositions
PL3454838T3 (en) Pharmaceutical composition
GB201615917D0 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
RS60551B1 (en) Pharmaceutical composition
IL265436B (en) Pharmaceutical composition
PL3424500T3 (en) Pharmaceutical composition comprising famitinib
GB2529605B (en) Pharmaceutical composition
IL265428A (en) Pharmaceutical composition
PT3476391T (en) Pharmaceutical composition
GB201620519D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)